QUINSAIR

This brand name is authorized in Austria, Canada, Croatia, Estonia, Finland, Ireland, Italy, Lithuania, Netherlands, Poland, Spain, UK.

Active ingredients

The drug QUINSAIR contains one active pharmaceutical ingredient (API):

1	Levofloxacin UNII 6GNT3Y5LMF - LEVOFLOXACIN
	Levofloxacin is a synthetic antibacterial agent of the fluoroquinolone class. As a fluoroquinolone antibacterial agent, levofloxacin acts on the DNA – DNA-gyrase complex and topoisomerase IV.
	Read more about Levofloxacin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
QUINSAIR Nebuliser solution	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01MA12	Levofloxacin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01M Quinolone antibacterials → J01MA Fluoroquinolones
Discover more medicines within J01MA12

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	02442302
EE	Ravimiamet	1683121, 1849259
ES	Centro de información online de medicamentos de la AEMPS	114973001
FI	Lääkealan turvallisuus- ja kehittämiskeskus	427887
GB	Medicines & Healthcare Products Regulatory Agency	325074
IE	Health Products Regulatory Authority	88576
IT	Agenzia del Farmaco	044034015, 044034027
LT	Valstybinė vaistų kontrolės tarnyba	1076058, 1090526
NL	Z-Index G-Standaard, PRK	132586
PL	Rejestru Produktów Leczniczych	100342329